Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Acquires Contur Software for $13.1M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys said after the close of the market Monday that it has acquired electronic lab notebook software firm Contur Software for $13.1 million in cash.

Stockholm, Sweden-based Contur provides ELN capabilities on site as well as via a software-as-a-service model. Accelrys said that it will complement the Symyx Notebook that the firm acquired through its merger with Symyx last year.

"With the addition of Contur's software solutions, Accelrys now offers cost-effective ELNs to meet the range of needs of various scientific research and development teams — from R&D organizations transitioning from paper to an electronic notebook to those requiring a fully integrated electronic lab environment," Accelrys President and CEO Max Carnecchia said in a statement.

The purchase price includes $500,000 to be paid upon reaching certain agreed-upon milestones.

San Diego-based Accelrys does not expect the acquisition to have a material impact on its 2011 revenues or earnings per share.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.